Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00285935 · ClinicalTrials.gov registry record · NA

Cellular Aging and Neurobiology of Depression Study

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
228
Enrollment target

NCT00285935 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 228 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00285935, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
228 participants
Enrollment target

Study Summary

We are conducting an eight week longitudinal study to learn if blood levels of certain naturally occurring compounds and genetic markers differ between patients with depression and healthy adults who are not depressed, and if any such differences relate to memory performance, mood, and neurobiology. We are also interested in how the gut microbiome is affected by antidepressant treatment. We will do this by comparing the unmedicated depressed patients with matched healthy controls at baseline and then following the depressed patients over the course of eight weeks of standardized antidepressant treatment to gauge which baseline abnormalities normalize over the course of treatment.

Interventions

  • OTHER Standard Clinical Care with an SSRI

Trial Details

FieldValue
Enrollment Target 228 participants
Start Date 2010-12-16
Est. Completion 2025-08-22
Phase NA

What the Registry Record Tells You About NCT00285935

The ClinicalTrials.gov registry entry for NCT00285935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Standard Clinical Care with an SSRI is the first listed.

NCT00285935 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00285935 about?

NCT00285935 is a clinical study titled "Cellular Aging and Neurobiology of Depression Study". We are conducting an eight week longitudinal study to learn if blood levels of certain naturally occurring compounds and genetic markers differ between patients with depression and healthy adults who are not depressed, and if any such differences relate to memory performance, mood, and neurobiology....

What is the current status of trial NCT00285935?

This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2010-12-16. Estimated completion is 2025-08-22.

What interventions are being tested in trial NCT00285935?

The interventions under investigation include: Standard Clinical Care with an SSRI (OTHER).

Who is sponsoring clinical trial NCT00285935?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.